
Open Your Free Demat Account
Enjoy low brokerage on delivery trades
BAJAJ BROKING
Dabur India has launched ‘Siens’, a digital-first wellness brand in the nutraceuticals space. The product range targets beauty, gut health, and immunity. Backed by science and global sourcing, the brand marks Dabur’s foray into precision wellness solutions.
Dabur India has formally entered the nutraceuticals segment with the launch of its digital-first brand ‘Siens by Dabur’. This strategic move signals Dabur’s shift into evidence-based wellness, with products developed using clinically researched ingredients across three essential health domains—Beauty and Skin Health, Daily Wellness, and Gut Health.
Also read: Siemens Energy Lists on NSE & BSE from June 19 After Demerger
Brand Name: Siens (pronounced “Science”)
Product Categories: Beauty & Skin Health, Daily Wellness, Gut Health
Sales Model: Digital-first, D2C across e-commerce platforms
Core Products: Collagen, Omega-3, multivitamins, prebiotics, probiotics
Manufacturing Standards: GMP, ISO, HACCP certified facilities
Distribution: Available via DaburShop and leading e-commerce portals
Also read: Abbott to Distribute MSD India’s Sitagliptin-Based Diabetes Drugs
Category | Key Products |
Beauty & Skin Health | Marine Collagen, Hair-Skin-Nails Gummies |
Daily Wellness | Men’s and Women’s Multivitamins, Omega-3 |
Gut Health | Daily Prebiotics and Probiotics |
The products under Siens are formulated with globally sourced ingredients that meet clinical standards for efficacy. Dabur has leveraged its decades-long brand trust to create a wellness solution that meets evolving consumer demands for scientifically validated supplements.
Siens is Dabur’s first digitally native brand and will operate primarily in the direct-to-consumer space. The brand is available through major e-commerce platforms and DaburShop, the company’s proprietary online storefront. This channel-first strategy reflects the rising digital health trend in India, especially among younger, health-conscious urban consumers.
The launch not only adds a new revenue stream to Dabur’s portfolio but also aligns with the broader consumer shift toward precision-based nutrition and wellness products. As global and Indian markets alike witness a surge in nutraceutical demand, Dabur’s entry is poised to capture a significant share in this fast-growing segment.
Despite the announcement, Dabur share price ended lower on June 18. Investors may adopt a wait-and-watch approach as the company tests market traction for its new brand. However, the success of Siens could influence long-term sentiment and positively affect the Dabur share price. As product adoption scales, the Dabur share price could also reflect improved brand diversification and digital sales performance.
Also read: ESAF Small Finance Bank to Offload Rs.735 Crore Bad Loan Pool to ARC
Source: Economic Times
Share this article:
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading